Literature DB >> 12816984

Thy-1 signaling in the context of costimulation provided by dendritic cells provides signal 1 for T cell proliferation and cytotoxic effector molecule expression, but fails to trigger delivery of the lethal hit.

S M Mansour Haeryfar1, Monther M Al-Alwan, Jamie S Mader, Geoffry Rowden, Kenneth A West, David W Hoskin.   

Abstract

Cross-linking of the GPI-anchored protein Thy-1 results in T cell proliferation and IL-2 synthesis. However, the exact function of Thy-1 in the process of T cell activation remains unknown, as does the effect of costimulation on Thy-1-driven T cell responses. In this study, we have investigated the ability of Thy-1 to substitute for traditional signal 1 in the context of costimulation provided by dendritic cells. Dendritic cells dramatically enhanced T cell proliferation and IL-2 synthesis in response to Thy-1 triggering by anti-Thy-1 mAb. This effect was not dependent on dendritic cell Fcgamma receptors, but was a result of B7-mediated costimulation (signal 2). T cells were also activated when microbeads coated with a combination of anti-Thy-1 and anti-CD28 mAbs were used to supply signals 1 and 2, respectively. Thy-1-stimulated T cells adhere to target cells and express perforin, granzyme B, and Fas ligand, but fail to kill target cells due to an inability to reorganize their secretion machinery. Moreover, in contrast to TCR signaling, Thy-1 triggering failed to induce cytotoxicity in redirected lysis assays. We conclude that Thy-1 triggering can partially substitute for signal 1, which, in combination with a strong signal 2, leads to robust T cell proliferation, IL-2 synthesis, and cytotoxic effector molecule expression, but does not induce cytolytic function. The block at the level of cytotoxic effector function that results when T cells are activated in the absence of a classical, Ag-specific signal 1 may constitute a mechanism to ensure the specificity of CTL responses and prevent potentially harmful promiscuous cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12816984     DOI: 10.4049/jimmunol.171.1.69

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Engagement of glycosylphosphatidylinositol-anchored proteins results in enhanced mouse and human invariant natural killer T cell responses.

Authors:  Lisa A Mannik; Ian Chin-Yee; Shayan Sharif; Luc Van Kaer; Terry L Delovitch; S M Mansour Haeryfar
Journal:  Immunology       Date:  2010-11-11       Impact factor: 7.397

2.  Thymus cell antigen 1 (Thy1, CD90) is expressed by lymphatic vessels and mediates cell adhesion to lymphatic endothelium.

Authors:  Giorgia Jurisic; Maria Iolyeva; Steven T Proulx; Cornelia Halin; Michael Detmar
Journal:  Exp Cell Res       Date:  2010-06-23       Impact factor: 3.905

Review 3.  Thy-1, a versatile modulator of signaling affecting cellular adhesion, proliferation, survival, and cytokine/growth factor responses.

Authors:  Tanya A Rege; James S Hagood
Journal:  Biochim Biophys Acta       Date:  2006-08-18

Review 4.  NKT cell costimulation: experimental progress and therapeutic promise.

Authors:  Marianne J van den Heuvel; Nitan Garg; Luc Van Kaer; S M Mansour Haeryfar
Journal:  Trends Mol Med       Date:  2010-11-17       Impact factor: 11.951

5.  Direct Thy-1/alphaVbeta3 integrin interaction mediates neuron to astrocyte communication.

Authors:  Tamara Hermosilla; Daniel Muñoz; Rodrigo Herrera-Molina; Alejandra Valdivia; Nicolás Muñoz; Sang-Uk Nham; Pascal Schneider; Keith Burridge; Andrew F G Quest; Lisette Leyton
Journal:  Biochim Biophys Acta       Date:  2008-02-20

6.  Improved Murine MHC-Deficient HLA Transgenic NOD Mouse Models for Type 1 Diabetes Therapy Development.

Authors:  Jeremy J Racine; Isabel Stewart; Jeremy Ratiu; Greg Christianson; Emily Lowell; Kelsay Helm; Jennifer Allocco; Richard S Maser; Yi-Guang Chen; Cathleen M Lutz; Derry Roopenian; Jennifer Schloss; Teresa P DiLorenzo; David V Serreze
Journal:  Diabetes       Date:  2018-02-22       Impact factor: 9.461

7.  Thy-1 (CD90) Signaling Preferentially Promotes RORγt Expression and a Th17 Response.

Authors:  Suzanne Furlong; Melanie R Power Coombs; Javad Ghassemi-Rad; David W Hoskin
Journal:  Front Cell Dev Biol       Date:  2018-11-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.